<DOC>
	<DOCNO>NCT02669628</DOCNO>
	<brief_summary>The purpose multicenter study evaluate ovarian reserve alcohol sclerotherapy endometriomas versus conventional surgery .</brief_summary>
	<brief_title>Antimullerian Hormone Endometriomas</brief_title>
	<detailed_description>Between 5-10 % fertile woman affect endometriosis , ovarian endometrioma present 17-44 % case , 40 % patient endometriomas sterile . However , `` gold standard '' treatment laparoscopic ovarian cystectomy therapy associate diminished ovarian reserve , significant antimullerian hormone ( AMH ) decrease . Alcohol sclerotherapy new minimal invasive procedure endometrioma treatment whose potential beneficial effect fertility preservation still demonstrate . The investigator would like demonstrate procedure improve fertility preservation reduces morbidity cost contrast conventional surgery . Moreover , investigator would like demonstrate procedure could perform different center similar result .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Women Age â‰¥18 &lt; 40 year Unilocular endometrioma accord ultrasound Endometrioma size : 35100 mm &gt; 3 month diagnosis CA125 &lt; 200 IU/mL HE4 &lt; 70 , AMH previous surgery 1.24 ng/mL Previous ovarian surgery gynecological cancer Severe extraovarian endometriosis Dermoid high risk malignancy cysts Hormonal treatment 3 month Pregnancy Mental disability</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>